Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 9, 2023
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
Jamie Perse Maintained (AGL) at Strong Buy with Decreased Target to $22 on, Nov 9th, 2023
Jamie Perse of Goldman Sachs, Maintained "agilon health, inc." (AGL) at Strong Buy with Decreased Target from $25 to $22 on, Nov 9th, 2023.
Jamie has made no other calls on AGL in the last 4 months.
There are 3 other peers that have a rating on AGL. Out of the 3 peers that are also analyzing AGL, 0 agree with Jamie's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jamie
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $23 on, Friday, November 3rd, 2023
- Bill Sutherland of "Benchmark" Initiated at Strong Buy and Held Target at $28 on, Friday, October 20th, 2023
- Gary Taylor of "TD Cowen" Maintained at Buy with Decreased Target to $25 on, Tuesday, August 15th, 2023
